The company lowered its full-year outlook while targeting $1B in sales and 15% EBITDA margin long-term.
Nature’s Sunshine Products revised its 2026 sales outlook downward to $490M-$500M, despite reporting 4% constant-currency growth in Q2 2026. The company cited continued momentum in strategic initiatives, including 5% growth in Asia Pacific, as key drivers for the quarter.
Management previously aimed for higher revenue but maintained a long-term target of $1B in sales and a 15% EBITDA margin. The adjustment reflects a shift in near-term expectations while preserving ambitious profitability goals.
Shares showed limited immediate reaction as investors weighed the revised outlook against ongoing operational improvements.